These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 12066054)

  • 21. Review: clinical inertia in the management of chronic obstructive pulmonary disease.
    Cooke CE; Sidel M; Belletti DA; Fuhlbrigge AL
    COPD; 2012 Feb; 9(1):73-80. PubMed ID: 22292599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
    Wurst KE; Shukla A; Muellerova H; Davis KJ
    COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shortness of breath--is it chronic obstructive pulmonary disease?
    McDonald CF
    Aust Fam Physician; 2005 Jul; 34(7):541-5. PubMed ID: 15999164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Update on current care guidelines: Chronic obstructive pulmonary disease, diagnosis and treatment].
    Duodecim; 2010; 126(3):317-9. PubMed ID: 20402041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Innovations to achieve excellence in COPD diagnosis and treatment in primary care.
    Fromer L; Barnes T; Garvey C; Ortiz G; Saver DF; Yawn B
    Postgrad Med; 2010 Sep; 122(5):150-64. PubMed ID: 20861599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice.
    Chalmers JD; Tebboth A; Gayle A; Ternouth A; Ramscar N
    NPJ Prim Care Respir Med; 2017 Jun; 27(1):43. PubMed ID: 28663549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic obstructive pulmonary disease treatment options.
    George DL
    J Manag Care Pharm; 2004 Jul; 10(4 Suppl):S11-6. PubMed ID: 15253682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of chronic obstructive pulmonary disease medications: a primary care perspective.
    Hanania NA
    Postgrad Med; 2011 May; 123(3):72-9. PubMed ID: 21566417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Management of COPD: a review].
    Steurer-Stey C
    Praxis (Bern 1994); 2004 Oct; 93(41):1673-8. PubMed ID: 15535600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Earlier diagnosis and earlier treatment of COPD in primary care.
    Price D; Freeman D; Cleland J; Kaplan A; Cerasoli F
    Prim Care Respir J; 2011 Mar; 20(1):15-22. PubMed ID: 20871945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Individualizing the selection of long-acting bronchodilator therapy for patients with COPD: considerations in primary care.
    Carlin BW; Schuldheisz SK; Noth I; Criner GJ
    Postgrad Med; 2017 Sep; 129(7):725-733. PubMed ID: 28707495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COPD management by Swedish general practitioners - baseline results of the PRIMAIR study.
    Sandelowsky H; Natalishvili N; Krakau I; Modin S; Ställberg B; Nager A
    Scand J Prim Health Care; 2018 Mar; 36(1):5-13. PubMed ID: 29334861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and validation of the Salzburg COPD-screening questionnaire (SCSQ): a questionnaire development and validation study.
    Weiss G; Steinacher I; Lamprecht B; Kaiser B; Mikes R; Sator L; Hartl S; Wagner H; Studnicka M
    NPJ Prim Care Respir Med; 2017 Jan; 27(1):4. PubMed ID: 28127061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: in UK primary care: a real-world, retrospective, observational.
    Gruffydd-Jones K; Brusselle G; Jones R; Miravitlles M; Baldwin M; Stewart R; Rigazio A; Davis E; Keininger DL; Price D
    NPJ Prim Care Respir Med; 2016 Feb; 26():16002. PubMed ID: 28358398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care.
    O'Donnell DE; Hernandez P; Kaplan A; Aaron S; Bourbeau J; Marciniuk D; Balter M; Ford G; Gervais A; Lacasse Y; Maltais F; Road J; Rocker G; Sin D; Sinuff T; Voduc N
    Can Respir J; 2008; 15 Suppl A(Suppl A):1A-8A. PubMed ID: 18292855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survey to determine the efficacy and safety of guideline-based pharmacological therapy for chronic obstructive pulmonary disease patients not previously receiving maintenance treatment.
    Setoguchi Y; Izumi S; Nakamura H; Hanada S; Marumo K; Kurosaki A; Akata S
    Expert Opin Pharmacother; 2015; 16(15):2271-81. PubMed ID: 26290277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of a network of primary care physicians and an open spirometry programme for COPD diagnosis.
    Konstantikaki V; Kostikas K; Minas M; Batavanis G; Daniil Z; Gourgoulianis KI; Hatzoglou C
    Respir Med; 2011 Feb; 105(2):274-81. PubMed ID: 20663655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NICE guidelines for chronic obstructive pulmonary disease--a review.
    Fehrenbach C
    Nurs Times; 2004 Jun 15-21; 100(24):48-51. PubMed ID: 15224493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initial diagnosis and management of chronic obstructive pulmonary disease in Australia: views from the coal face.
    Bereznicki B; Walters H; Walters J; Peterson G; Bereznicki L
    Intern Med J; 2017 Jul; 47(7):807-813. PubMed ID: 28276136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacological treatment of COPD. Where are we now?].
    Calle Rubio M; Pinedo Sierra C; Rodríguez Hermosa JL
    Arch Bronconeumol; 2010 Dec; 46 Suppl 10():3-7. PubMed ID: 21316549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.